Top ▲
Target id: 2013
Nomenclature: dual specificity tyrosine phosphorylation regulated kinase 4
Abbreviated Name: DYRK4
Family: Dyrk1 subfamily
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 520 | 12p13.32 | DYRK4 | dual specificity tyrosine phosphorylation regulated kinase 4 | |
Mouse | - | 632 | 6 F3 | Dyrk4 | dual-specificity tyrosine phosphorylation regulated kinase 4 | |
Rat | - | - | 4 q42 | Dyrk4 | dual specificity tyrosine phosphorylation regulated kinase 4 |
Previous and Unofficial Names |
RAD51 associated protein 1 | Rad51ap1 | dual specificity tyrosine-(Y)-phosphorylation regulated kinase 4 |
Database Links | |
Alphafold | Q9NR20 (Hs), Q8BI55 (Mm) |
BRENDA | 2.7.12.1 |
ChEMBL Target | CHEMBL1075115 (Hs) |
Ensembl Gene | ENSG00000010219 (Hs), ENSMUSG00000030345 (Mm), ENSRNOG00000053178 (Rn) |
Entrez Gene | 8798 (Hs), 101320 (Mm), 312721 (Rn) |
Human Protein Atlas | ENSG00000010219 (Hs) |
KEGG Enzyme | 2.7.12.1 |
KEGG Gene | hsa:8798 (Hs), mmu:101320 (Mm), rno:312721 (Rn) |
OMIM | 609181 (Hs) |
Pharos | Q9NR20 (Hs) |
RefSeq Nucleotide | NM_003845 (Hs), NM_207210 (Mm) |
RefSeq Protein | NP_003836 (Hs), NP_997093 (Mm) |
UniProtKB | Q9NR20 (Hs), Q8BI55 (Mm) |
Wikipedia | DYRK4 (Hs) |
Enzyme Reaction | ||||
|
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||
|
EMD Millipore KinaseProfilerTM screen/Reaction Biology Kinase HotspotSM screen | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A screen profiling 158 kinase inhibitors (Calbiochem Protein Kinase Inhibitor Library I and II, catalogue numbers 539744 and 539745) for their inhibitory activity at 1µM and 10µM against 234 human recombinant kinases using the EMD Millipore KinaseProfilerTM service. A screen profiling the inhibitory activity of 178 commercially available kinase inhibitors at 0.5µM against a panel of 300 recombinant protein kinases using the Reaction Biology Corporation Kinase HotspotSM platform. http://www.millipore.com/techpublications/tech1/pf3036 http://www.reactionbiology.com/webapps/main/pages/kinase.aspx Reference: ...1 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target used in screen: nd/DYRK4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Displaying the top 10 most potent ligands View all ligands in screen » |
1. Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR. (2011) Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1039-45. [PMID:22037377]
2. Tahtouh T, Elkins JM, Filippakopoulos P, Soundararajan M, Burgy G, Durieu E, Cochet C, Schmid RS, Lo DC, Delhommel F et al.. (2012) Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B. J Med Chem, 55 (21): 9312-30. [PMID:22998443]
Dyrk1 subfamily: dual specificity tyrosine phosphorylation regulated kinase 4. Last modified on 30/03/2016. Accessed on 03/12/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetomalariapharmacology.org/GRAC/ObjectDisplayForward?objectId=2013.